Vaxcyte Statistics
NASDAQ: PCVXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
66.96+0.26 (+0.39%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 66.60 -0.54%
Vaxcyte by the numbers
Vaxcyte has a market capitalization of $9.96 billion based on 148.81M shares outstanding. With trailing EPS of $-7.62, Vaxcyte is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.2% above its 50-day average and 20.9% above its 200-day average.
Average daily trading volume is 1.50M shares, or about $100.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PCVX valuation vs. peer median
| Metric | PCVX | Peer median | Difference |
|---|---|---|---|
| Market cap | $9.96B | $10.33B | -4% |
| Avg. volume | 1.50M | 2.05M | -27% |
Peer median across 8 companies: KRYS, TWST, IBRX, QGEN, RGEN, KYMR, TECH, HALO.
Valuation
- Market cap
- $9.96B
- EPS (TTM)
- $-7.62
- Shares outstanding
- 148.81M
Price and trading
- Previous close
- 66.70
- Open
- 65.86
- Day range
- 64.27 – 67.15
- 52-week range
- 39.87 – 90.75
- 52-week change
- +59.92%
- Beta
- —
- Volume
- 11.56M
- Average volume
- 1.50M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 9.96B
- Forward Pe
- -8.89
- Eps
- -7.62
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 90.75
- Week52 Low
- 39.87
- Avg Volume
- 1.50M
- Shares Outstanding
- 148.81M
- Ma50
- 59.15
- Ma200
- 55.41
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -26.21%
- Pct From52w Low
- 67.95%